Marker improvement · January 2026

Plant Sterols

A strong marker-improvement record for the most obvious cholesterol intervention in my stack. The useful signal is what happened to ApoB, LDL-C, and total cholesterol after the red/yellow lipid panel. Personal marker history with overlapping interventions, documented rather than prescribed or offered as an instruction to copy.

Experiment window: August 25, 2025 to Jan 16, 2026. Did plant sterols, as part of the cholesterol stack, earn a permanent place after the August 25, 2025 lipid panel?

Bloodwork Story

Why this date matters

The August 25, 2025 bloodwork is the decision anchor. It showed ApoB at 87 yellow, LDL-C at 113 red, and total cholesterol at 216 red. That lipid panel is the reason this plant sterol entry belongs in the experiment record.

What changed

By January 16, 2026, ApoB was 66 green, LDL-C was 77 green, and total cholesterol was 151 green. Plant sterols were the intervention most directly mapped to the cholesterol problem within the larger lipid stack.

How I read it

This is a marker-success story within a larger pattern that also includes omega-3, green tea extract, artichoke extract, training, diet, and body-composition changes. Plant sterols stay in the stack because the follow-up panel moved the exact markers they were meant to move.

Marker Record

ApoB

Aug 25, 2025 87 yellow

Jan 16, 2026 66 green

Direct improvement after the August 2025 cholesterol panel.

LDL Cholesterol

Aug 25, 2025 113 red

Jan 16, 2026 77 green

Moved from red to green by January 2026.

Total Cholesterol

Aug 25, 2025 216 red

Jan 16, 2026 151 green

Elevated at baseline, then clearly back in range.

The Experiment

Current stack entry

2 g per day from NOW Beta Sitosterol Plant Sterols.

Protocol

The logged stack entry is 2 g per day of plant sterols after the daily large meal. This page documents the current entry and anchors the experiment to the August 25, 2025 marker problem. It is not a suggested protocol.

Primary markers

The primary markers are ApoB, LDL-C, and total cholesterol. The decision is mostly about whether the atherogenic-marker pattern stays improved.

Decision rule

Plant sterols keep their place if repeat panels continue to show a favorable ApoB and LDL-C pattern without creating an obvious tolerance problem or crowding out higher-value basics.